ARKG vs SQQQ
ARK Genomic Revolution ETF vs ProShares UltraPro Short QQQ
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SQQQ—
ProShares UltraPro Short QQQ
3x inverse daily performance of the Nasdaq-100.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SQQQ |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | ProShares |
ARKG top holdings
Holdings data unavailable for ARKG.
SQQQ top holdings
Holdings data unavailable for SQQQ.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SQQQ
SQQQ (ProShares UltraPro Short QQQ) is 3x inverse daily performance of the Nasdaq-100.